Prognostic Biomarkers for Anti‐<scp>PD</scp>‐1 Monoclonal Antibodies in the First Line Treatment of Advanced Melanoma
Elevated pretreatment levels of SII and LDH were shown to be independent negative prognostic factors for OS. According to the nomogram for OS, which considers a combination of pretreatment parameters including LDH and SII, it is possible to predict 24-month OS in the first line of anti-PD-1 therapy.
Authors
- Emanuel Marques (ORCID: https://orcid.org/0000-0003-1451-6115)
- Petr Arenberger (ORCID: https://orcid.org/0000-0002-4800-5877)
- David Šulc
- Marek Pásek (ORCID: https://orcid.org/0009-0000-0875-8332)
- Jiří Šilar (ORCID: https://orcid.org/0009-0008-1290-947X)
- Monika Arenbergerová (ORCID: https://orcid.org/0000-0002-7919-9619)
- Vojtěch Tretera (ORCID: https://orcid.org/0009-0002-5557-6026)
Institutions
- Charles University (CZ)
- Krajská Zdravotní (CZ)
- Universidade Nova de Lisboa (PT)
Publication Details
- Journal
- International Journal of Dermatology
- Published
- 2025-06-27
- DOI
- https://doi.org/10.1111/ijd.17842
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- Univerzita Karlova v Praze